Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meglumine Antimoniate vs Miltefosine for Cutaneous Leishmaniasis
TCTR20251022011Phase 1Completed
- Sponsor
- Combined Military Hospital Quetta
- Start
- Jan 2025
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in cutaneous leishmaniasis (CL) comparing Meglumine Antimoniate with Miltefosine (2 arms). Primary endpoints: Clinical efficacy and Safety. Started Jan 2025; status: completed.
02
Drugs
meglumine antimoniatemiltefosine
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on TCTR20251022011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251022011.